In a report issued on June 24, Marie Thibault from BTIG maintained a Buy rating on Accuray (ARAY – Research Report), with a price target of $7.00. The company's shares closed last Friday at $2.06, close to its 52-week low of $1.70. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 6.2% and a 27.2% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Accuray with a $7.50 average price target.
https://www.tipranks.com/news/blurbs/btig-thinks-accurays-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Accuray Charts.
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Accuray Charts.